Variant report
Variant | nsv1007312 |
---|---|
Chromosome Location | chr2:76544454-76582327 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:76545602..76547142-chr2:76580181..76582795,2 | K562 | blood: | |
2 | chr2:76542822..76545873-chr2:76546426..76549641,3 | K562 | blood: | |
3 | chr2:76545602..76547142-chr2:76580181..76582795,2 | K562 | blood: | |
4 | chr2:76542822..76545873-chr2:76546426..76549641,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183067044 | chr2:76544528-76544529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs551902821 | chr2:76544543-76544544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139473886 | chr2:76544584-76544585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115069282 | chr2:76544591-76544592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555602837 | chr2:76544597-76544598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573704208 | chr2:76544627-76544628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374124374 | chr2:76544733-76544734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556513444 | chr2:76544801-76544802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186292326 | chr2:76544833-76544834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192389439 | chr2:76544870-76544871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560124810 | chr2:76544941-76544942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182438482 | chr2:76544966-76544967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10599833 | chr2:76545003-76545004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572726094 | chr2:76545004-76545005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200471210 | chr2:76545005-76545006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs67704981 | chr2:76545013-76545014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201038793 | chr2:76545020-76545021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13009875 | chr2:76545031-76545032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187812882 | chr2:76545064-76545065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192439397 | chr2:76545089-76545090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531341368 | chr2:76545116-76545117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549551260 | chr2:76545130-76545131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571217702 | chr2:76545170-76545171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13422380 | chr2:76545193-76545194 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs547450771 | chr2:76545222-76545223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35193185 | chr2:76545327-76545328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144182942 | chr2:76545333-76545334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566737090 | chr2:76545405-76545406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72807129 | chr2:76545438-76545439 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs7587657 | chr2:76545468-76545469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs62163964 | chr2:76545492-76545493 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs187174129 | chr2:76545521-76545522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571503871 | chr2:76545527-76545528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368733721 | chr2:76545538-76545539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577956583 | chr2:76545552-76545553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191905306 | chr2:76545597-76545598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538884257 | chr2:76545598-76545599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs554211251 | chr2:76545613-76545614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557412717 | chr2:76545622-76545623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572272615 | chr2:76545624-76545625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563733732 | chr2:76545631-76545632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561053426 | chr2:76545673-76545674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs114514643 | chr2:76545674-76545675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149235739 | chr2:76545690-76545691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184335361 | chr2:76545708-76545709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532095996 | chr2:76545740-76545741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1358177 | chr2:76545748-76545749 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs558986025 | chr2:76545750-76545751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529733657 | chr2:76545761-76545762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190265420 | chr2:76545778-76545779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76544200-76544600 | Enhancers | Fetal Heart | heart |
2 | chr2:76544600-76546000 | Weak transcription | Fetal Heart | heart |
3 | chr2:76546000-76546400 | Enhancers | Fetal Heart | heart |
4 | chr2:76549600-76551200 | Enhancers | Fetal Brain Male | brain |
5 | chr2:76550200-76551200 | Enhancers | Fetal Brain Female | brain |
6 | chr2:76550600-76551000 | Enhancers | Hela-S3 | cervix |
7 | chr2:76551200-76552800 | Weak transcription | Fetal Brain Male | brain |
8 | chr2:76552800-76553000 | Enhancers | Fetal Brain Male | brain |
9 | chr2:76557000-76557400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr2:76577800-76578800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr2:76578400-76579200 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
12 | chr2:76578800-76584000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr2:76579200-76581600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
14 | chr2:76580600-76582200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr2:76581000-76581400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr2:76581600-76582000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr2:76581600-76582000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |